カテゴリー： 世界, 医療/バイオ, QYResearch

グセルクマブ注射の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Guselkumab Injection Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10367）・商品コード：QY22JLX10367
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：73
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、グセルクマブ注射のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にグセルクマブ注射の世界市場のxxx％を占める「100mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「尋常性乾癬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
グセルクマブ注射の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのグセルクマブ注射市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

グセルクマブ注射のグローバル主要企業には、Janssen Biotechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

グセルクマブ注射市場は、種類と用途によって区分されます。世界のグセルクマブ注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
100mg、その他

【用途別セグメント】
尋常性乾癬、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- グセルクマブ注射製品概要
- 種類別市場（100mg、その他）
- 用途別市場（尋常性乾癬、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のグセルクマブ注射販売量予測2017-2028
- 世界のグセルクマブ注射売上予測2017-2028
- グセルクマブ注射の地域別販売量
- グセルクマブ注射の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別グセルクマブ注射販売量
- 主要メーカー別グセルクマブ注射売上
- 主要メーカー別グセルクマブ注射価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（100mg、その他）
- グセルクマブ注射の種類別販売量
- グセルクマブ注射の種類別売上
- グセルクマブ注射の種類別価格
・用途別市場規模（尋常性乾癬、その他）
- グセルクマブ注射の用途別販売量
- グセルクマブ注射の用途別売上
- グセルクマブ注射の用途別価格
・北米市場
- 北米のグセルクマブ注射市場規模（種類別、用途別）
- 主要国別のグセルクマブ注射市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのグセルクマブ注射市場規模（種類別、用途別）
- 主要国別のグセルクマブ注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のグセルクマブ注射市場規模（種類別、用途別）
- 主要国別のグセルクマブ注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のグセルクマブ注射市場規模（種類別、用途別）
- 主要国別のグセルクマブ注射市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのグセルクマブ注射市場規模（種類別、用途別）
- 主要国別のグセルクマブ注射市場規模（トルコ、サウジアラビア）
・企業情報
Janssen Biotech
・産業チェーン及び販売チャネル分析
- グセルクマブ注射の産業チェーン分析
- グセルクマブ注射の原材料
- グセルクマブ注射の生産プロセス
- グセルクマブ注射の販売及びマーケティング
- グセルクマブ注射の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- グセルクマブ注射の産業動向
- グセルクマブ注射のマーケットドライバー
- グセルクマブ注射の課題
- グセルクマブ注射の阻害要因
・主な調査結果

Market Analysis and Insights: Global Guselkumab Injection Market
Due to the COVID-19 pandemic, the global Guselkumab Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100mg Type accounting for % of the Guselkumab Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Plaque Psoriasis segment is altered to an % CAGR throughout this forecast period.
China Guselkumab Injection market size is valued at US$ million in 2021, while the US and Europe Guselkumab Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Guselkumab Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Guselkumab Injection include Janssen Biotech. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Guselkumab Injection Scope and Segment
Guselkumab Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Guselkumab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100mg Type
Other
Segment by Application
Plaque Psoriasis
Other
By Company
Janssen Biotech
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Guselkumab Injection Product Introduction
1.2 Market by Type
1.2.1 Global Guselkumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100mg Type
1.2.3 Other
1.3 Market by Application
1.3.1 Global Guselkumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Plaque Psoriasis
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Guselkumab Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Guselkumab Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Guselkumab Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Guselkumab Injection Sales by Region
2.4.1 Global Guselkumab Injection Sales by Region (2017-2022)
2.4.2 Global Sales Guselkumab Injection by Region (2023-2028)
2.5 Global Guselkumab Injection Revenue by Region
2.5.1 Global Guselkumab Injection Revenue by Region (2017-2022)
2.5.2 Global Guselkumab Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Guselkumab Injection Sales by Manufacturers
3.1.1 Global Top Guselkumab Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Guselkumab Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Guselkumab Injection in 2021
3.2 Global Guselkumab Injection Revenue by Manufacturers
3.2.1 Global Guselkumab Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Guselkumab Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Guselkumab Injection Revenue in 2021
3.3 Global Guselkumab Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Guselkumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Guselkumab Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Guselkumab Injection Sales by Type
4.1.1 Global Guselkumab Injection Historical Sales by Type (2017-2022)
4.1.2 Global Guselkumab Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Guselkumab Injection Sales Market Share by Type (2017-2028)
4.2 Global Guselkumab Injection Revenue by Type
4.2.1 Global Guselkumab Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Guselkumab Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Guselkumab Injection Revenue Market Share by Type (2017-2028)
4.3 Global Guselkumab Injection Price by Type
4.3.1 Global Guselkumab Injection Price by Type (2017-2022)
4.3.2 Global Guselkumab Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Guselkumab Injection Sales by Application
5.1.1 Global Guselkumab Injection Historical Sales by Application (2017-2022)
5.1.2 Global Guselkumab Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Guselkumab Injection Sales Market Share by Application (2017-2028)
5.2 Global Guselkumab Injection Revenue by Application
5.2.1 Global Guselkumab Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Guselkumab Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Guselkumab Injection Revenue Market Share by Application (2017-2028)
5.3 Global Guselkumab Injection Price by Application
5.3.1 Global Guselkumab Injection Price by Application (2017-2022)
5.3.2 Global Guselkumab Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Guselkumab Injection Market Size by Type
6.1.1 North America Guselkumab Injection Sales by Type (2017-2028)
6.1.2 North America Guselkumab Injection Revenue by Type (2017-2028)
6.2 North America Guselkumab Injection Market Size by Application
6.2.1 North America Guselkumab Injection Sales by Application (2017-2028)
6.2.2 North America Guselkumab Injection Revenue by Application (2017-2028)
6.3 North America Guselkumab Injection Market Size by Country
6.3.1 North America Guselkumab Injection Sales by Country (2017-2028)
6.3.2 North America Guselkumab Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Guselkumab Injection Market Size by Type
7.1.1 Europe Guselkumab Injection Sales by Type (2017-2028)
7.1.2 Europe Guselkumab Injection Revenue by Type (2017-2028)
7.2 Europe Guselkumab Injection Market Size by Application
7.2.1 Europe Guselkumab Injection Sales by Application (2017-2028)
7.2.2 Europe Guselkumab Injection Revenue by Application (2017-2028)
7.3 Europe Guselkumab Injection Market Size by Country
7.3.1 Europe Guselkumab Injection Sales by Country (2017-2028)
7.3.2 Europe Guselkumab Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Guselkumab Injection Market Size by Type
8.1.1 Asia Pacific Guselkumab Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Guselkumab Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Guselkumab Injection Market Size by Application
8.2.1 Asia Pacific Guselkumab Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Guselkumab Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Guselkumab Injection Market Size by Region
8.3.1 Asia Pacific Guselkumab Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Guselkumab Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Guselkumab Injection Market Size by Type
9.1.1 Latin America Guselkumab Injection Sales by Type (2017-2028)
9.1.2 Latin America Guselkumab Injection Revenue by Type (2017-2028)
9.2 Latin America Guselkumab Injection Market Size by Application
9.2.1 Latin America Guselkumab Injection Sales by Application (2017-2028)
9.2.2 Latin America Guselkumab Injection Revenue by Application (2017-2028)
9.3 Latin America Guselkumab Injection Market Size by Country
9.3.1 Latin America Guselkumab Injection Sales by Country (2017-2028)
9.3.2 Latin America Guselkumab Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Guselkumab Injection Market Size by Type
10.1.1 Middle East and Africa Guselkumab Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Guselkumab Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Guselkumab Injection Market Size by Application
10.2.1 Middle East and Africa Guselkumab Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Guselkumab Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Guselkumab Injection Market Size by Country
10.3.1 Middle East and Africa Guselkumab Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Guselkumab Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Janssen Biotech
11.1.1 Janssen Biotech Corporation Information
11.1.2 Janssen Biotech Overview
11.1.3 Janssen Biotech Guselkumab Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Janssen Biotech Guselkumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Janssen Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Guselkumab Injection Industry Chain Analysis
12.2 Guselkumab Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Guselkumab Injection Production Mode & Process
12.4 Guselkumab Injection Sales and Marketing
12.4.1 Guselkumab Injection Sales Channels
12.4.2 Guselkumab Injection Distributors
12.5 Guselkumab Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Guselkumab Injection Industry Trends
13.2 Guselkumab Injection Market Drivers
13.3 Guselkumab Injection Market Challenges
13.4 Guselkumab Injection Market Restraints
14 Key Findings in The Global Guselkumab Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Guselkumab Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100mg Type
Table 3. Major Manufacturers of Other
Table 4. Global Guselkumab Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Guselkumab Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Guselkumab Injection Sales by Region (2017-2022) & (K Units)
Table 7. Global Guselkumab Injection Sales Market Share by Region (2017-2022)
Table 8. Global Guselkumab Injection Sales by Region (2023-2028) & (K Units)
Table 9. Global Guselkumab Injection Sales Market Share by Region (2023-2028)
Table 10. Global Guselkumab Injection Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Guselkumab Injection Revenue Market Share by Region (2017-2022)
Table 12. Global Guselkumab Injection Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Guselkumab Injection Revenue Market Share by Region (2023-2028)
Table 14. Global Guselkumab Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Guselkumab Injection Sales Share by Manufacturers (2017-2022)
Table 16. Global Guselkumab Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Guselkumab Injection Revenue Share by Manufacturers (2017-2022)
Table 18. Guselkumab Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Guselkumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Guselkumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guselkumab Injection as of 2021)
Table 21. Guselkumab Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Guselkumab Injection Product Offered
Table 23. Date of Manufacturers Enter into Guselkumab Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 26. Global Guselkumab Injection Sales by Type (2023-2028) & (K Units)
Table 27. Global Guselkumab Injection Sales Share by Type (2017-2022)
Table 28. Global Guselkumab Injection Sales Share by Type (2023-2028)
Table 29. Global Guselkumab Injection Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Guselkumab Injection Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Guselkumab Injection Revenue Share by Type (2017-2022)
Table 32. Global Guselkumab Injection Revenue Share by Type (2023-2028)
Table 33. Guselkumab Injection Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Guselkumab Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 36. Global Guselkumab Injection Sales by Application (2023-2028) & (K Units)
Table 37. Global Guselkumab Injection Sales Share by Application (2017-2022)
Table 38. Global Guselkumab Injection Sales Share by Application (2023-2028)
Table 39. Global Guselkumab Injection Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Guselkumab Injection Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Guselkumab Injection Revenue Share by Application (2017-2022)
Table 42. Global Guselkumab Injection Revenue Share by Application (2023-2028)
Table 43. Guselkumab Injection Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Guselkumab Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 46. North America Guselkumab Injection Sales by Type (2023-2028) & (K Units)
Table 47. North America Guselkumab Injection Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Guselkumab Injection Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 50. North America Guselkumab Injection Sales by Application (2023-2028) & (K Units)
Table 51. North America Guselkumab Injection Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Guselkumab Injection Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 54. North America Guselkumab Injection Sales by Country (2023-2028) & (K Units)
Table 55. North America Guselkumab Injection Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Guselkumab Injection Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 58. Europe Guselkumab Injection Sales by Type (2023-2028) & (K Units)
Table 59. Europe Guselkumab Injection Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Guselkumab Injection Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 62. Europe Guselkumab Injection Sales by Application (2023-2028) & (K Units)
Table 63. Europe Guselkumab Injection Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Guselkumab Injection Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 66. Europe Guselkumab Injection Sales by Country (2023-2028) & (K Units)
Table 67. Europe Guselkumab Injection Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Guselkumab Injection Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Guselkumab Injection Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Guselkumab Injection Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Guselkumab Injection Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Guselkumab Injection Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Guselkumab Injection Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Guselkumab Injection Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Guselkumab Injection Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Guselkumab Injection Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Guselkumab Injection Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Guselkumab Injection Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Guselkumab Injection Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Guselkumab Injection Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Guselkumab Injection Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Guselkumab Injection Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Guselkumab Injection Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Guselkumab Injection Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Guselkumab Injection Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Guselkumab Injection Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Guselkumab Injection Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Guselkumab Injection Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Guselkumab Injection Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Guselkumab Injection Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Guselkumab Injection Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Guselkumab Injection Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Guselkumab Injection Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Guselkumab Injection Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Guselkumab Injection Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Guselkumab Injection Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Guselkumab Injection Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Guselkumab Injection Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Guselkumab Injection Revenue by Country (2023-2028) & (US$ Million)
Table 105. Janssen Biotech Corporation Information
Table 106. Janssen Biotech Description and Major Businesses
Table 107. Janssen Biotech Guselkumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Janssen Biotech Guselkumab Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Janssen Biotech Recent Developments
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Guselkumab Injection Distributors List
Table 113. Guselkumab Injection Customers List
Table 114. Guselkumab Injection Market Trends
Table 115. Guselkumab Injection Market Drivers
Table 116. Guselkumab Injection Market Challenges
Table 117. Guselkumab Injection Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Guselkumab Injection Product Picture
Figure 3. Global Guselkumab Injection Market Share by Type in 2021 & 2028
Figure 3. 100mg Type Product Picture
Figure 4. Other Product Picture
Figure 5. Global Guselkumab Injection Market Share by Application in 2021 & 2028
Figure 6. Plaque Psoriasis
Figure 7. Other
Figure 8. Guselkumab Injection Report Years Considered
Figure 9. Global Guselkumab Injection Sales 2017-2028 (K Units)
Figure 10. Global Guselkumab Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Guselkumab Injection Revenue 2017-2028 (US$ Million)
Figure 12. Global Guselkumab Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Guselkumab Injection Sales Market Share by Region (2017-2022)
Figure 14. Global Guselkumab Injection Sales Market Share by Region (2023-2028)
Figure 15. North America Guselkumab Injection Sales YoY (2017-2028) & (K Units)
Figure 16. North America Guselkumab Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Guselkumab Injection Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Guselkumab Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Guselkumab Injection Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Guselkumab Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Guselkumab Injection Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Guselkumab Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Guselkumab Injection Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Guselkumab Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Guselkumab Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Guselkumab Injection in the World: Market Share by Guselkumab Injection Revenue in 2021
Figure 27. Global Guselkumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Guselkumab Injection Sales Market Share by Type (2017-2028)
Figure 29. Global Guselkumab Injection Revenue Market Share by Type (2017-2028)
Figure 30. Global Guselkumab Injection Sales Market Share by Application (2017-2028)
Figure 31. Global Guselkumab Injection Revenue Market Share by Application (2017-2028)
Figure 32. North America Guselkumab Injection Sales Market Share by Type (2017-2028)
Figure 33. North America Guselkumab Injection Revenue Market Share by Type (2017-2028)
Figure 34. North America Guselkumab Injection Sales Market Share by Application (2017-2028)
Figure 35. North America Guselkumab Injection Revenue Market Share by Application (2017-2028)
Figure 36. North America Guselkumab Injection Sales Share by Country (2017-2028)
Figure 37. North America Guselkumab Injection Revenue Share by Country (2017-2028)
Figure 38. United States Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Guselkumab Injection Sales Market Share by Type (2017-2028)
Figure 41. Europe Guselkumab Injection Revenue Market Share by Type (2017-2028)
Figure 42. Europe Guselkumab Injection Sales Market Share by Application (2017-2028)
Figure 43. Europe Guselkumab Injection Revenue Market Share by Application (2017-2028)
Figure 44. Europe Guselkumab Injection Sales Share by Country (2017-2028)
Figure 45. Europe Guselkumab Injection Revenue Share by Country (2017-2028)
Figure 46. Germany Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 47. France Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Guselkumab Injection Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Guselkumab Injection Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Guselkumab Injection Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Guselkumab Injection Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Guselkumab Injection Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Guselkumab Injection Revenue Share by Region (2017-2028)
Figure 57. China Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 60. India Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Guselkumab Injection Sales Market Share by Type (2017-2028)
Figure 67. Latin America Guselkumab Injection Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Guselkumab Injection Sales Market Share by Application (2017-2028)
Figure 69. Latin America Guselkumab Injection Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Guselkumab Injection Sales Share by Country (2017-2028)
Figure 71. Latin America Guselkumab Injection Revenue Share by Country (2017-2028)
Figure 72. Mexico Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Guselkumab Injection Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Guselkumab Injection Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Guselkumab Injection Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Guselkumab Injection Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Guselkumab Injection Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Guselkumab Injection Revenue Share by Country (2017-2028)
Figure 81. Turkey Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Guselkumab Injection Revenue (2017-2028) & (US$ Million)
Figure 84. Guselkumab Injection Value Chain
Figure 85. Guselkumab Injection Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed


★調査レポート[グセルクマブ注射の世界市場インサイト・予測（～2028年）] (コード：QY22JLX10367)販売に関する免責事項を必ずご確認ください。
★調査レポート[グセルクマブ注射の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • ダラツムマブ注射の世界市場インサイト・予測（～2028年）
  • 注射ペプチド薬の世界市場インサイト・予測（～2028年）
  • 注入用ヒアルロン酸の世界市場インサイト・予測（～2028年）
  • 注射用グルコン酸カルシウムの世界市場インサイト・予測（～2028年）
  • 皮内注射装置の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆